What did Vital Healthcare Property Trust announce?

Vital Healthcare Property Trust (NZX: VHP) filed “Vital Governance Roadshow” with NZX on 7 October 2026, as a board change announcement.

When was it filed?
7 October 2026
Where is the original?
NZX announcement
Vital Healthcare Property Trust logo

Vital Governance Roadshow

Board Change7 October 2026VHPReal Estate

VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz Page 1 of 1

NZX RELEASE




8 October 2026

Vital Governance Roadshow presentation

Vital Healthcare Property Trust advises that it is conducting a series of investor meetings in relation to governance

matters.

The presentation material to be used during these meetings is attached.

– ENDS –


ENQUIRIES

Chris Adams

Chief Executive Officer, Vital Healthcare Properties Management Limited

Tel +61 408 665 332, Email chris.adams@vhpt.co.nz


Michael Groth

Chief Financial Officer, Vital Healthcare Properties Management Limited

Tel +61 409 936 104, Email michael.groth@vhpt.co.nz


Jarrod Gill

Head of Investor Relations, Vital Healthcare Properties Management Limited

Tel +61 408 612 998, Email jarrod.gill@vhpt.co.nz


About Vital (NZX code VHP):

Vital Healthcare Property Trust is an NZX-listed fund that invests in high-quality healthcare properties in New Zealand

and Australia including private hospitals (~79%* of portfolio value), ambulatory care facilities (~17%* of portfolio

value) and life science facilities (4%* of portfolio value).

Vital is the leading specialist listed landlord of healthcare property in Australasia.

For more information, please visit our website: www.vhpt.co.nz

* All figures are as at 30 June 2026, NZD/AUD exchange rate of 0.8213.

---

Governance Roadshow
Board and governance update for institutional investors

OCTOBER 2026

Presenters
What we’ll cover today

Epworth Eastern Hospital Precinct, VIC

Graham Stuart

Chair

Angela Bull

Independent Director and

Chair of the People and

Culture Committee

Governance progress from July 2025 to September 2026 (FY26 + YTD FY27)

InternalisationFrom external to internal management: deal, structure and rationale

FY26 Financial ResultsNumbers behind the transition: occupancy, gearing and earnings

Board Composition & RenewalIndependence, succession and the 2026 Annual Meeting

Committees & OversightAudit & Risk and People & Culture Committee structure

Remuneration FrameworkIndependently benchmarked and implemented

Risk Management and Capital GovernanceBalance sheet discipline through the transition

Forward Outlook2026 AGM elections and the governance calendar ahead

1

2

3

4

5

6

7

15 months in Governance
Transformational period through strengthened

governance

Wakefield Hospital, Wellington

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 3

52 days

From internalisation

announcement to completion

(9 Nov -31 Dec 2025)

~$20.9m

Expected normalised

annual savings from

internalised management

structure

4 of 6

Independent directors on

the Board today

+23.5%

Growth in AFFO to $86.9m

in FY26

2

Active Board committees:

Audit & Risk, People &

Culture

oversubscribed

Unit Purchase Plan (Dec

2025), backing the

internalisation

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 4
The deal at a glance

Announced 9 November 2025

Key Terms:

•Management internalised from Northwest Healthcare Properties

Management Limited

1

(‘Northwest’)

•NZ$214m (plus GST) management termination payment;

~NZ$177m net after-tax cost

•CEO Chris Adams and CFO Michael Groth retained, ensuring

management continuity

•Funded by a NZ$220m capital raise:

oNZ$190m placement at $1.95 (9.5% discount), plus

oNZ$30m unit purchase plan

•Independent expert confirmed benefits materially exceed costs

for unitholders

9 November 2025

Internalisation & $220m raise announced

14 November 2025

$190m placement settled

1-4 December 2025

Unit Purchase Plan priced, closes oversubscribed

22 December 2025

Conditions satisfied

31 December 2025

Internalisation completed

1: Effective11 March 2026Northwest Healthcare Properties Real Estate Investment Trust was renamed to Vital Healthcare Infrastructure Property Trust

Why it matters for Unit Holders
Cost Efficiency

1

~NZ$20.9m in expected normalised

annual savings versus the external

management & activity fee structure

Direct alignment between management and the trust

Direct Accountability

3

Management now sits inside the trust's

governance structure, reporting directly to

an independent-majority Board

Earnings Accretive

2

Transaction expected to be accretive to

Adjusted Funds From Operations (AFFO)

Growth Funding

4

Capital raise proceeds also support the

development pipeline, including Coomera

Stage 1A and Macarthur Stage 2

Avive Clinic –Mornington, VIC

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 5

FY26 annual results snapshot
VITALHEALTHCAREPROPERTYTRUST

|

PRESENTATIONTITLE

|

6

Essential Healthcare Infrastructure

Occupancy remains strong and gearing reduced

through active capital refinancing

$86.9m

Adjusted Funds From

Operations (AFFO) –up

23.5% on FY25

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 6

98.6%

42.1%

97.2%

39.6%

0.0%

20.0%

40.0%

60.0%

80.0%

100.0%

Occupancy (%)Gearing (%)

FY25FY26

9.75 cps

Full year distribution per

unit –maintained on FY25

$162.2m

Net property income –up

9% on FY25 with a $60.1m

unrealisedvaluation gain

4.1%

Increase in like-for-like

net property income (on

a constant currency)

Coomera Health Campus –Stage 1, QLD

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 7
Governance and management post-internalisation

A direct reporting line from management to an independent Board

UNITHOLDERS

Audit & Risk

Committee

Chair: Dr. Michael Stanford

People & Culture

Committee

Chair: Angela Bull

Internal Manager

Vital Healthcare Properties

Management Ltd

BOARD OF DIRECTORS

Executive Leadership Team

Chris Adams (CEO), Michael Groth (CFO) and Vanessa Flax (General Counsel)

Board Composition
Graham Stuart

Independent Chair

Audit & Risk Committee

Dr. Michael Stanford AM

Independent Director

Chair, Audit & Risk

Committee

Angela Bull

Independent Director

Chair, People & Culture

Committee

Mark Menhennitt

Independent Director

People & Culture Committee

(appointed June 2026)

Mike Brady

Northwest

Representative Director

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 8

Zachary Vaughan

Northwest

Representative Director

Audit & Risk, People &

Culture Committees

MAJORITY INDEPENDENT BOARD

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 9
Board Committees

Two standing committees, each governed by its own charter

Audit & Risk Committee

Financial reporting integrity, external audit, risk management

and internal controls.

CHAIR

MEMBERS

Dr. Michael Stanford AM

Graham Stuart

Zachary Vaughan

People & Culture Committee

Remuneration, culture, talent and people-related policy

across the newly internalisedteam.

CHAIR

MEMBERS

Angela Bull

Mark MenhinnittZachary Vaughan

Board Renewal and Succession
A steady cadence of refreshment through the internalisation period

Replacement of Northwest

Representative Director

1

2

3

21 July 2025

Director Nomination Process opened

for the 2025 Annual Meeting

22 August 2025

2025 Annual Meeting held

6 November 2025

Intention to appoint independent

director Mark Menhinnitt

announced (effective 1 September)

456

22 June 2026

Director Nomination Process

opened for the 2026 Annual

Meeting

27 August 2026

Dr. Michael Stanford AM and Mike Brady

retire by rotation; the Board endorses their

re-election, alongside Mark Menhennitt

standing for election for the first time

2026 Annual Meeting –

retirements and elections

The independent director count grew

from 3 to 4 in September 2026, moving

the Board to an independent majority

following internalisation.

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 10

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 11
Remuneration Framework -CEO

An independent, performance linked framework established following

internalisation

Governance & Process

Board directly responsible for

remuneration following internalisation

People & Culture Committee oversees

policy, executive performance and

incentive design

KPMG independently benchmarked

executive incentives and established the

LTIP

Short-term incentive

Long-term incentive

CEO opportunity: 35% of TEC

Annual cash incentive linked to financial,

strategic and operational performance

Board retains discretion to adjust STI

outcomes, if required

Performance HurdleWeighting

Financial Performance60%

Strategy15%

Portfolio10%

Development10%

People, Culture & Sustainability5%

CEO opportunity: 97.5% of fixed

remuneration

LTIP has two tranches:

1.Service Rights –32.5%;

Subject to service through the performance

period and further 2-year disposal restriction

2.Performance Rights –65.0%

Performance Rights assessed on relative TSR

against 19 NZX/ASX peers. Initial 2.5-year LTI

for the transition period (1 Jan 26 –30 Jun 28)

Vital’s relative TSR% maximum

Below the 40

th

percentileNil

40

th

percentile40% vesting

Between 40

th

& 50

th

Straight-line pro rata

50

th

percentile50% vesting

Between 50

th

& 75

th

Straight-line pro rata

At or above 75

th

100%

Remuneration Framework -Director
Director remuneration benchmarked

Director Remuneration

On completion of internalisation, PwC were commissioned to

independently benchmark non-executive Director fees

Post-internalisation:

-Chair $220k per annum

-Director $110k per annum +fee for respective committees

Any additional Board sub-committees formed will be subject to the

same fee structure

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 12

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 13
Capital governance through the transition

Balance sheet management stayed disciplined while internalisation was executed

Debt facilities extended

On improved terms and ahead of scheduled maturities:13 May 2026

Distribution Reinvestment Plan refreshed

Updated DRP terms adopted 13 August 2025. Strike prices and allotments disclosed every

quarter since

Unit Purchase Plan oversubscribed

The NZ$30m UPP supporting internalisation closed oversubscribed in December 2025

Growth capital redeployed

Placement and UPP proceeds directed to the development pipeline, including Coomera

Health Campus –Stage 1 and Macarthur Health Precinct –Stage 2

1

2

3

4

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 14
Risk Management Framework

A measured appetite for growth, a low appetite for balance sheet risk

Strategic ObjectivesUnitholder outcomes that every risk measure is anchored too

Board risk limits

Hard boundaries set inside Trust Deed and lender covenants. No

exceptions

Risk appetite parameters

Quantitative and qualitative measures that guide decisions and

capital allocation

Management escalationEarly triggers that prompt action well before a Board limit is reached

APPETITE ANCHORED TO THREE OBJECTIVES

FOUR TIERS –EVERY PARAMETER

FRAMEWORK HIERARCHY –OWNED BY THE BOARD

Sustainable AFFO & DPU growth Protect & grow NTA Support tenant infrastructure

REPORTED TO THE BOARD QUARTERLY –FRAMEWORK REVIEWED AT LEAST EVERY TWO YEARS

Target

Measured Approach

Caution

Breach

1

2

3

4

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 15
Forward Governance Calendar

Based on the trust’s established reporting cadence

Annual Meeting

Q1-FY27 results and distribution

November 2026

FY27 half-year results and distribution

February 2027

Next director nomination process and

FY27 full-year results and distribution

August 2027

1

2

3

Ekera Medical Centre, VIC

VITAL HEALTHCARE PROPERTY TRUST | GOVERNANCE ROADSHOW | 16
Key Takeaways

Internalisation executed cleanly

and quickly

1

Announced and completed within eight

weeks

FY26 results affirm the case

2

AFFO up 23.5% to $86.9m and gearing

reduced to 39.6%

Board independence

strengthened

3

Four out of six majority are independent,

with continued succession planning

Risk management framework and

capital governance

5

Risk management framework adopted and

remained disciplined throughout the

transition

2026 Annual Meeting

continues renewal

6

Dr. Michael Stanford AM and Mike Brady

stand for re-election and Mark Menhinnitt’s

first election

Remuneration framework

4

Independently benchmarked remuneration

framework implemented

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • PHL — Promisia Healthcare Limited: ASM 2026 Presentation
    2026-08-27

    “1 Annual Shareholders’ Meeting 27 August 2026 2 Board Rhonda Sherriff Chair and Independent Director Thomas Brankin Non-Independent Director 1 Tony Mortensen Non-Independent Director Jill Hatchwell Independent Director Craig Percy Independent Director Francisco Rodriguez Ferrer…”

  • PFI — Property for Industry Limited: Annual Meeting Presentation and Leasing Update
    2026-10-19

    “propertyforindustry.co.nz 20 October 2026 NZX and media announcement Property for Industry Limited (PFI) ANNUAL MEETING PRESENTATION AND LEASING UPDATE Property for Industry Limited (PFI) today holds its Annual Meeting of shareholders. It will be a hybrid…”

  • FBU — Fletcher Building: Proxy Advisor Presentation
    2026-09-29

    “Fletcher Building Limited, 810 Great South Road, Penrose, Auckland 1061, New Zealand 30 September 2026 Proxy Advisor Presentation Fletcher Building releases the attached presentation, which was prepared in connection with Fletcher Building’s upcoming engagement with pro…”